BioSpace News Archive

Genetown

Cancer Discovery Features H3 Biomedicine Paper Highlighting Effects of Selective Estrogen Receptor Covalent Antagonists (SERCAs) in ERα Wild-Type and Mutant Breast Cancer Models

Next-generation endocrine therapy exhibits differentiated mechanism of action versus standard-of-care therapies and potently inhibits the ERα pathway

July 10, 2018
·
4 min read
Policy

Sprint Bioscience Strengthens the Vps34 Project by Patenting the use of Newly Developed Biomarkers in Immune-oncology

Sprint Bioscience has developed biomarkers for the company’s anti-cancer project, Vps34.

July 10, 2018
·
2 min read
Pharm Country

Filament BioSolutions Announces Collaboration with Ajinomoto for the Development of FB-2710 for Radiation-Induced Oral MucositisFilament is expanding its product pipeline to include multiple oncology co-therapies

Filament BioSolutions announced continued progress in the development of its lead product FB-2710

July 10, 2018
·
3 min read
BioMidwest

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

July 10, 2018
·
2 min read
Business

Allogene Therapeutics Announces Scientific Advisory Board

Allogene Therapeutics, Inc. announced its Scientific Advisory Board (SAB), which is comprised of five experts in oncology, immunology, drug discovery and development.

July 10, 2018
·
7 min read
Drug Development

Aravive Biologics Completes Phase 1 Trial of Novel GAS6-AXL Pathway Inhibitor, AVB-S6-500

Aravive Biologics, Inc. announced that the company has completed both the single ascending dose and repeat dose portions of its Phase 1 study of AVB-S6-500 in healthy volunteers.

July 10, 2018
·
7 min read